Therapy News and Research

RSS

Laboratory testing kit that estimates risk of breast cancer relapse gets FDA approval

A laboratory testing kit that estimates the risk of breast cancer relapse in spite of anti-hormone treatment has received approval from the U.S. Food and Drug Administration.

2 Oct 2013

Genetic discovery could take guesswork out of prescribing correct dose of drugs

The discovery of genetic differences affecting up to a third of the population could take the guesswork out of prescribing the correct dose of 25 percent of drugs currently on the market, researchers say.

2 Oct 2013

Nia exercise benefits individuals with breast cancer

Researchers from ProMedica Cancer Institute have released new findings about the benefits of Nia exercise for individuals with breast cancer. Nia is a sensory-based movement practice that heals the body using music and movement.

2 Oct 2013

Remote stroke service increases rate of tPA therapy at community hospitals

A telestroke service increases the rate of effective tissue plasminogen activator therapy for patients with acute ischemic stroke treated at community hospitals, according to a report in the October issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

2 Oct 2013

Multiple aspects to severe bipolar mixed states

Researchers have identified four subgroups of severe bipolar mixed states, characterized by distinct symptomatologic presentations.

1 Oct 2013

Ilesto ICD/CRT-D devices from BIOTRONIK approved by FDA

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced it has received approval from the Food and Drug Administration (FDA) for its Ilesto family of implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillators (ICD/CRT-D devices). BIOTRONIK follows this milestone with the launch of its next generation unique technology platform Ilesto DX.

1 Oct 2013

Researchers compare cardiovascular safety of two commonly used oral estrogen medications

The oral hormone therapy conjugated equine estrogens, which is used by women to relieve menopause symptoms, appears to be associated with increased risk for venous thrombosis (VT, blood clots) and possibly myocardial infarction (heart attack), but not ischemic stroke risk, when compared with the hormone therapy oral estradiol, according to a study published by JAMA Internal Medicine, a JAMA Network publication.

1 Oct 2013

Sun Pharma, Intrexon Team Up To Target Ocular Diseases

...

1 Oct 2013

Overactive bladder treatments: an interview with Professor Chris Chapple, Consultant Urological Surgeon at the Royal Hallamshire Hospital and Sheffield Teaching Hospitals NHS Foundation Trust

Overactive bladder symptom complex is a symptom complex, the pivotal symptom of which is urgency, which is a compelling desire to pass urine, which is difficult to defer.

1 Oct 2013

Canada should start screening 'Baby Boomers' for hepatitis C virus infection, say liver specialists

Canada should begin screening 'Baby Boomers' for the hepatitis C virus infection, since this age group is likely the largest group to have the illness, and most don't know they have it, say a group of liver specialists in the Toronto Western Hospital Francis Family Liver Clinic. Unlike many other chronic viral infections, early treatment makes hepatitis C curable.

1 Oct 2013

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.

1 Oct 2013

Pitt scientists open door to potential research into cures for Parkinson's disease

A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.

1 Oct 2013

Sun Pharma, Intrexon partner to develop controllable gene-based therapies for ocular diseases

Sun Pharmaceutical Industries Ltd., an international specialty pharmaceutical company focused on chronic diseases, through its subsidiary, and Intrexon Corporation, a leader in synthetic biology, today announced the formation of a joint venture to develop controllable gene-based therapies for the treatment of ocular diseases that cause partial or total blindness in millions of people worldwide.

1 Oct 2013

New approaches needed for testing cancer drugs

Research institutes, regulators and the pharmaceutical industry are urged to cooperate to develop new approaches to testing cancer drugs, in order to bring the revolution in personalised medicine to patients across Europe, says the European Society for Medical Oncology.

1 Oct 2013

Circassia reports positive results from phase II clinical study of ToleroMune grass allergy treatment

Circassia Ltd, a specialty biopharmaceutical company focused on developing world-class immunotherapies, today announced successful results from a large phase II clinical study of its ToleroMune® grass allergy treatment (Grass-Synthetic Peptide Immuno-Regulatory Epitope [Grass-SPIRE])

1 Oct 2013

Researchers discover how aspirin improves survival in patients diagnosed with colon cancer

Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress (ECC2013) heard today.

1 Oct 2013

Emotion regulation training enhances efficacy of inpatient cognitive behavioral therapy for MDD

A new psychotherapeutic ingredient, emotion regulation skills training, has been found to enhance standard cognitive behavior therapy for depression in a trial published in the current issue of Psychotherapy and Psychosomatics.

1 Oct 2013

Preoperative statin therapy improves results for isolated CABG and AVR operations

Patients receiving statin therapy before coronary artery bypass grafting (CABG) surgery appear to have a reduced risk of post-surgical mortality, stroke, and atrial fibrillation (irregular or rapid heart rate), according to an article in the October 2013 issue of The Annals of Thoracic Surgery.

1 Oct 2013

Mayo Clinic researchers to develop innovative medical treatments for wounded veterans

Mayo Clinic researchers are part of the second phase of a national consortium that focuses on developing innovative medical treatments for wounded veterans. Mayo's role will emphasize peripheral nerve regeneration.

1 Oct 2013

Researchers develop C6 compound that prevents abnormalities linked with priapism in mice

It's not the little blue pill famous for helping men get big results, but for those who need it, the outcome might be even more significant. A new research report published online in The FASEB Journal, offers hope to men who experience priapism. This condition, which is often seen in men with sickle cell disease, causes erections lasting so long that they cause permanent damage to the penis.

1 Oct 2013

Therapy News and Research

Laboratory testing kit that estimates risk of breast cancer relapse gets FDA approval

Genetic discovery could take guesswork out of prescribing correct dose of drugs

Nia exercise benefits individuals with breast cancer

Remote stroke service increases rate of tPA therapy at community hospitals

Multiple aspects to severe bipolar mixed states

Ilesto ICD/CRT-D devices from BIOTRONIK approved by FDA

Researchers compare cardiovascular safety of two commonly used oral estrogen medications

Sun Pharma, Intrexon Team Up To Target Ocular Diseases

Overactive bladder treatments: an interview with Professor Chris Chapple, Consultant Urological Surgeon at the Royal Hallamshire Hospital and Sheffield Teaching Hospitals NHS Foundation Trust

Canada should start screening 'Baby Boomers' for hepatitis C virus infection, say liver specialists

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

Pitt scientists open door to potential research into cures for Parkinson's disease

Sun Pharma, Intrexon partner to develop controllable gene-based therapies for ocular diseases

New approaches needed for testing cancer drugs

Circassia reports positive results from phase II clinical study of ToleroMune grass allergy treatment

Researchers discover how aspirin improves survival in patients diagnosed with colon cancer

Emotion regulation training enhances efficacy of inpatient cognitive behavioral therapy for MDD

Preoperative statin therapy improves results for isolated CABG and AVR operations

Mayo Clinic researchers to develop innovative medical treatments for wounded veterans

Researchers develop C6 compound that prevents abnormalities linked with priapism in mice

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News